Latest filing published 13 Jul 2026 for Esperion Therapeutics, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Seth H. Z. Fischer across 6 companies, led by Marinus Pharmaceuticals, Inc., Spectrum Pharmaceuticals Inc and Agile Therapeutics Inc. Over a trading history stretching from 26 September 2016 to 13 July 2026, the count stands at 29 filings.
Sales make up the whole of the open-market record (3 sales, €53k). Outside the open market, there are 19 share grants and 1 option exercise.
The record was last updated on 13 July 2026 with a transaction in Esperion Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations